In two rented rooms in Malmö, Sweden, Dr. Frederik Paulsen founded Nordiska Hormon Laboratoriet in 1950, which in 1954 changed its name to Ferring. He named the company after the strong, closely knit community of people originating from the island Föhr who called themselves Feringers, and spoke Fering.
World leader in peptide hormones
Ferring became a pioneer in developing and selling pharmaceutical products based upon natural, pituitary-produced peptide hormones. Dr. Paulsen was convinced that these new compounds could be used to supplement deficiencies and correct abnormalities, thus playing an invaluable role in the treatment of life-threatening conditions.
Five decades later, Dr. Paulsen's predictions have proved remarkably accurate. Today, peptides from Ferring are widely used in Ferring's treatments. The development of the product MINIRIN (desmopressin), used to treat nocturnal enuresis, or bedwetting, formed the basis of Ferring's international expansion and boosted revenues from the late 1980s on.
The message has been sent
Your friend has been sent the following email: